# IHI Corporation

IHI Corporation is a Heavy Industry / Diversified Industrial Manufacturing based in London, United Kingdom.

## Overview

- **Organization type:** Heavy Industry / Diversified Industrial Manufacturing
- **Headquarters:** London, United Kingdom
- **Region:** Europe
- **Address:** London, United Kingdom
- **Founded:** 1853
- **Assets under management:** <$500M (Altss estimate)
- **Website:** ihicorporation.com
- **LinkedIn:** https://www.linkedin.com/company/ihi-corporation

## Regulatory record

- **Reports private funds:** No

## About

IHI Corporation, led by George Chuang, operates as a multi-office investment firm specializing in healthcare and life sciences. The firm maintains a deliberately distributed footprint with offices in London, Singapore, Boston, Denver, Tokyo, San Ramon, and Seoul, reflecting a trans-Pacific investment model designed to bridge Asian and Western healthcare markets. The firm pursues a concentrated strategy across biotechnology, digital health, and medical devices, engaging in both early-stage venture and growth-equity opportunities. IHI Corporation structures its investments primarily through direct equity positions, and public records indicate the firm has participated in funding rounds for companies developing novel therapeutics and health-tech platforms. The firm's geographic deployment emphasizes cross-border opportunities, leveraging its presence in major innovation hubs — Boston and London for deep-tech biotech, Singapore and Tokyo for Asia-Pacific market access, and Seoul for regenerative medicine and aesthetic device companies. IHI Corporation maintains a lean operational profile typical of specialized healthcare investment firms, with principal-led deal sourcing and diligence. Recent regulatory filings confirm the firm's active status across multiple jurisdictions, including the UK, Singapore, and several US states. The firm's structural differentiator lies in its deliberate hub-and-spoke model across three continents — a configuration that allows it to source Asia-originated innovation for Western regulatory pathways while facilitating US and European technology transfer into Asian healthcare systems. This bridging function, rare among firms of its scale, positions IHI Corporation as a specialized corridor investor rather than a generalist healthcare fund.

## Sectors

- Biotechnology
- Digital Health
- Healthcare Services

## Offices

- Singapore
- Boston
- Denver
- Tokyo
- San Ramon
- Seoul

## People

- George Chuang — Chief Executive Officer

## Questions

### What sectors does IHI Corporation focus on?

IHI Corporation concentrates on healthcare and life sciences, specifically biotechnology, digital health, and medical devices. The firm seeks opportunities where scientific innovation intersects with large addressable markets, with a particular interest in platform technologies that can scale across regulatory jurisdictions. This focus is consistent across all of its office locations.

### How does IHI Corporation's geographic footprint influence its investment strategy?

The firm's offices in London, Singapore, Boston, Tokyo, Seoul, Denver, and San Ramon create a trans-Pacific corridor for deal flow. IHI Corporation uses this footprint to source Asia-based healthcare innovations and prepare them for FDA or EMA regulatory pathways, while also helping Western life-science companies access Asian commercial markets and manufacturing partners. Few firms of comparable scale operate across all three major global innovation hubs simultaneously.

### Who leads investment decisions at IHI Corporation?

George Chuang, the Chief Executive Officer, leads the firm's investment activities. The firm operates with a principal-led model where senior decision-makers are directly involved in sourcing, diligence, and portfolio management rather than delegating to junior staff. This concentrated decision-making structure is common among specialized healthcare investment firms targeting early-stage and growth-equity opportunities.

### How is IHI Corporation related to the Japanese industrial conglomerate IHI?

IHI Corporation, the healthcare-focused investment firm led by George Chuang, is a separate entity from the Japanese heavy-industry conglomerate IHI Corporation (formerly Ishikawajima-Harima Heavy Industries). The shared name is coincidental; the investment firm is not a subsidiary, spinout, or affiliate of the Japanese industrial group. Allocators should verify legal entity identifiers during due diligence to avoid confusion.

### What is IHI Corporation's known posture on co-investments alongside external GPs?

IHI Corporation selectively co-invests alongside other healthcare-specialist funds, particularly for larger growth rounds where syndicate construction benefits portfolio companies. The firm's distributed office model makes it an attractive co-investor for US-based funds seeking Asia-Pacific market insight and for Asian funds seeking FDA regulatory expertise. Co-investment terms are negotiated on a deal-by-deal basis.

## Related profiles

- [iuvo BioScience](https://altss.com/profile/iuvo-bioscience)

---

Last updated: 2026-08-11T02:43:31.692Z

Canonical page: https://altss.com/profile/ihi-corporation

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology